Sort by

Nobivac NXT® 3-Rabies

The first and only 0.5 mL non-adjuvanted rabies vaccine for both cats and dogs.

icon: arrow-right LEARN MORE

Nobivac NXT® 1-Rabies

The first and only 0.5 mL non-adjuvanted rabies vaccine for both cats and dogs.

icon: arrow-right LEARN MORE

Nobivac® NXT Canine Flu H3N2

First and only canine flu vaccine built on RNA particle technology

icon: arrow-right LEARN MORE

Nobivac® Canine 3-DAPv

For the vaccination of healthy dogs against canine distemper virus, CPV and in the prevention of disease caused by canine adenovirus.

icon: arrow-right LEARN MORE

Nobivac® Canine 1-Pv

For vaccination of healthy dogs 6-weeks or older against canine parvovirus (CPV).

icon: arrow-right LEARN MORE

Nobivac® Canine 1-DAPPvL₂+Cv

For the vaccination of healthy dogs against canine distemper virus, canine adenovirus (Types 1 and 2), canine coronavirus, CPIV, CPV, Leptospira canicola and Leptospira icterohaemorrhagiae.

icon: arrow-right LEARN MORE

NOBIVAC® Canine 1-DAPPvL2

For the vaccination of healthy dogs against canine distemper virus, canine adenovirus (Types 1 and 2), CPIV, CPV, Leptospira canicola and Leptospira icterohaemorrhagiae.

icon: arrow-right LEARN MORE

NOBIVAC® Canine 1-DAPPv+Cv

For the vaccination of healthy dogs against canine distemper virus, adenovirus (Types 1 and 2), CPIV, CPV and canine coronavirus.

icon: arrow-right LEARN MORE

NOBIVAC® Canine 1-DAPPv+L₄

For the vaccination of healthy dogs against canine distemper virus, CPIV, CPV and Leptospirosis.

icon: arrow-right LEARN MORE

NOBIVAC® Canine 1-DAPPv

For vaccination of healthy dogs against canine distemper virus, canine adenovirus (Types 1 and 2), CPIV and CPV.

icon: arrow-right LEARN MORE

Nobivac® Canine 1-Cv

For the vaccination of healthy dogs, designed to enhance the immune response and offer protection against canine coronavirus.

icon: arrow-right LEARN MORE

Nobivac® 3-Rabies CA

NOBIVAC 3-RABIES CA vaccine meets state guidelines and is approved for sale in California to protect pets against rabies.

icon: arrow-right LEARN MORE